VRNA

Verona Pharma plc

Sales chart range
Log in to watch VRNA
Latest sale
$142k
Aug 1 · No plan
Form 4 sales
114
On record
Form 144 notices
6
Proposed sales
Next unlock
None
No lockup ahead

Lockups

No lockup on record.

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Timeline

  1. 1 Form 4 saleNo plan
    Aug 1 2025

    Sold 824 shares at $13.14 ($11k)

    Brady James Aloysius, Director

    No 10b5-1 planSold 3.4% of holdings ($315k position)23,176 shares leftFirst sale on recordFiling

  2. 2 Form 4 saleUnusual
    Aug 1 same day

    Sold 11,288 shares at $13.14 ($148k)

    Austwick Michael, Director

    No 10b5-1 planSold 47% of holdings ($315k position)12,712 shares leftFirst sale on recordFiling

  3. 3 Form 4 saleNo plan
    Aug 1 same day

    Sold 1,808 shares at $13.14 ($24k)

    Ackermann Christina, Director

    No 10b5-1 planSold 2.7% of holdings ($866k position)64,072 shares leftFiling

  4. 4 Form 4 saleRoutine
    Aug 1 same day

    Sold 58,336 shares at $13.14 ($767k)

    Rickard Kathleen A., Chief Medical Officer

    10b5-1 planSold 2.2% of holdings ($35M position)2.6M shares left1x usual sizeFiling

  5. 5 Form 4 saleRoutine
    Aug 1 same day

    Sold 208,912 shares at $13.14 ($2.7M)

    Hahn Mark W, Chief Financial Officer

    10b5-1 planSold 1.6% of holdings ($167M position)12.5M shares left0.6x usual sizeFiling

  6. 6 Form 4 saleNo plan
    Aug 1 same day

    Sold 9,584 shares at $13.14 ($126k)

    Fisher Andrew, General Counsel

    No 10b5-1 planSold 2.2% of holdings ($5.6M position)417,903 shares left0.1x usual sizeFiling

  7. 7 Form 4 saleNo plan
    Aug 1 same day

    Sold 9,464 shares at $13.14 ($124k)

    Deschamps Lisa, Director

    No 10b5-1 planSold 10% of holdings ($1.2M position)84,856 shares leftFirst sale on recordFiling

  8. 8 Form 4 saleNo plan
    Aug 1 same day

    Sold 10,808 shares at $13.14 ($142k)

    Cunningham Kenneth, Director

    No 10b5-1 planSold 11.9% of holdings ($1.2M position)79,776 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales, notices and lockups (120)

Export watchlist as CSV
Lockups, Form 144 notices and Form 4 sales for VRNA
Source
Aug 1, 2025Cunningham KennethDirectorForm 4 sale10,808$142k11.9%No planSEC
Aug 1, 2025Deschamps LisaDirectorForm 4 sale9,464$124k10.0%No planSEC
Aug 1, 2025Fisher AndrewGeneral CounselForm 4 sale9,584$126k2.2%No planSEC
Aug 1, 2025Hahn Mark WChief Financial OfficerForm 4 sale208,912$2.7M1.6%RoutineSEC
Aug 1, 2025Rickard Kathleen A.Chief Medical OfficerForm 4 sale58,336$767k2.2%RoutineSEC
Aug 1, 2025Ackermann ChristinaDirectorForm 4 sale1,808$24k2.7%No planSEC
Aug 1, 2025Austwick MichaelDirectorForm 4 sale11,288$148k47.0%UnusualSEC
Aug 1, 2025Brady James AloysiusDirectorForm 4 sale824$11k3.4%No planSEC
Aug 1, 2025Zaccardelli DavidPresident and CEOForm 4 sale208,912$2.7M1.5%RoutineSEC
Aug 1, 2025Ebsworth David RDirectorForm 4 sale1,904$25k0.2%No planSEC
Aug 1, 2025Edwards MartinDirectorForm 4 sale10,808$142k6.4%No planSEC
Aug 1, 2025Shah MahendraDirectorForm 4 sale3,608$47k3.7%No planSEC
Aug 1, 2025Sinha VikasDirectorForm 4 sale4,328$57k4.4%No planSEC
Jun 16, 2025Fisher AndrewGeneral CounselForm 4 sale80,000$922k18.2%RoutineSEC
Jun 11, 2025Hahn Mark WChief Financial OfficerForm 4 sale400,000$4.6M3.2%RoutineSEC
Jun 11, 2025Zaccardelli DavidPresident and CEOForm 4 sale400,000$4.6M2.9%RoutineSEC
May 29, 2025Hahn Mark WChief Financial OfficerForm 4 sale400,000$3.7M3.1%RoutineSEC
May 29, 2025Zaccardelli DavidPresident and CEOForm 4 sale400,000$3.7M2.9%RoutineSEC
May 20, 2025Sinha VikasDirectorForm 4 sale160,000$1.5M68.2%RoutineSEC
May 15, 2025Fisher AndrewGeneral CounselForm 4 sale80,000$686k18.2%RoutineSEC
May 14, 2025Ackermann ChristinaDirectorForm 4 sale40,000$338k48.9%RoutineSEC
May 6, 2025Rickard Kathleen A.Chief Medical OfficerForm 4 sale114,984$1M4.3%RoutineSEC
May 2, 2025Hahn Mark WChief Financial OfficerForm 4 sale587,008$5.3M4.3%UnusualSEC
May 2, 2025Zaccardelli DavidPresident and CEOForm 4 sale587,008$5.3M4.0%UnusualSEC
May 1, 2025Rickard Kathleen A.Chief Medical OfficerForm 4 sale49,200$440k1.8%RoutineSEC
Apr 29, 2025Fisher AndrewGeneral CounselForm 4 sale26,072$234k6.8%No planSEC
Apr 29, 2025Zaccardelli DavidPresident and CEOForm 4 sale90,360$811k0.6%RoutineSEC
Apr 29, 2025Rickard Kathleen A.Chief Medical OfficerForm 4 sale34,384$309k1.3%RoutineSEC
Apr 29, 2025Hahn Mark WChief Financial OfficerForm 4 sale90,360$811k0.7%RoutineSEC
Apr 29, 2025Sinha VikasDirectorForm 4 sale20,000$178k21.2%RoutineSEC
Mar 12, 2025Rickard Kathleen A.Chief Medical OfficerForm 4 sale79,264$662k2.9%RoutineSEC
Dec 6, 2024Zaccardelli DavidPresident and CEOForm 4 sale870,672$4.4M5.8%UnusualSEC
Dec 6, 2024Hahn Mark WChief Financial OfficerForm 4 sale881,960$4.4M6.2%UnusualSEC
Dec 2, 2024Hahn Mark WChief Financial OfficerForm 4 sale113,240$567k0.8%RoutineSEC
Dec 2, 2024Zaccardelli DavidPresident and CEOForm 4 sale125,328$627k0.8%RoutineSEC
Nov 26, 2024Hahn Mark WChief Financial OfficerForm 4 sale2,400$12k0.0%RoutineSEC
Nov 25, 2024Zaccardelli DavidPresident and CEOForm 4 sale1,600$8k0.0%RoutineSEC
Nov 25, 2024Rickard Kathleen A.Chief Medical OfficerForm 4 sale240,000$1.2M8.2%RoutineSEC
Nov 25, 2024Rickard Kathleen A.OfficerForm 144 notice30,000$1.2MNoticeSEC
Nov 11, 2024Zaccardelli DavidPresident and CEOForm 4 sale2,400$12k0.0%RoutineSEC
Nov 11, 2024Hahn Mark WChief Financial OfficerForm 4 sale2,400$12k0.0%RoutineSEC
Nov 4, 2024Zaccardelli DavidPresident and CEOForm 4 sale141,032$619k0.9%RoutineSEC
Nov 4, 2024Hahn Mark WChief Financial OfficerForm 4 sale129,672$569k0.9%RoutineSEC
Oct 25, 2024Hahn Mark WChief Financial OfficerForm 4 sale144,560$633k1.0%RoutineSEC
Oct 25, 2024Zaccardelli DavidPresident and CEOForm 4 sale144,816$634k1.0%RoutineSEC
Oct 22, 2024Zaccardelli DavidPresident and CEOForm 4 sale514,152$2.3M3.4%RoutineSEC
Oct 22, 2024Hahn Mark WChief Financial OfficerForm 4 sale525,768$2.3M3.7%RoutineSEC
Sep 11, 2024Zaccardelli DavidPresident and CEOForm 4 sale600,000$2.3M3.8%RoutineSEC
Sep 11, 2024Hahn Mark WChief Financial OfficerForm 4 sale600,000$2.3M4.0%RoutineSEC
Aug 13, 2024Zaccardelli DavidPresident and CEOForm 4 sale400,000$1.3M2.5%RoutineSEC
Aug 13, 2024Hahn Mark WChief Financial OfficerForm 4 sale400,000$1.3M2.6%RoutineSEC
May 3, 2024Rickard Kathleen A.Chief Medical OfficerForm 4 sale36,248$71k1.4%RoutineSEC
Feb 5, 2024Rickard Kathleen A.Chief Medical OfficerForm 4 sale36,248$80k1.3%RoutineSEC
Nov 3, 2023Rickard Kathleen A.Chief Medical OfficerForm 4 sale58,752$113k2.0%RoutineSEC
Nov 3, 2023Rickard Kathleen A.OfficerForm 144 notice7,344$110kNoticeSEC
Aug 7, 2023Rickard Kathleen A.Chief Medical OfficerForm 4 sale80,144$203k2.7%RoutineSEC
Aug 7, 2023Zaccardelli DavidPresident and CEOForm 4 sale275,888$694k1.7%UnusualSEC
Aug 7, 2023Hahn Mark WChief Financial OfficerForm 4 sale275,888$694k1.7%RoutineSEC
Aug 7, 2023Poll ClaireGeneral CounselForm 4 sale48,472$122k2.5%RoutineSEC
Aug 3, 2023Rickard Kathleen A.OfficerForm 144 notice3,594$74kNoticeSEC
Aug 2, 2023Hahn Mark WChief Financial OfficerForm 4 sale179,648$475k1.1%UnusualSEC
Aug 2, 2023Poll ClaireGeneral CounselForm 4 sale31,552$83k1.6%RoutineSEC
Aug 2, 2023Zaccardelli DavidPresident and CEOForm 4 sale179,648$475k1.1%UnusualSEC
Aug 2, 2023Rickard Kathleen A.Chief Medical OfficerForm 4 sale33,464$88k1.1%RoutineSEC
May 15, 2023Orbimed Advisors LLCDirectorForm 4 sale482,913$9.9M11.3%No planSEC
May 15, 2023Gupta RishiDirectorForm 4 sale482,913$9.9M11.3%No planSEC
May 11, 2023Orbimed Advisors LLCShareholderForm 144 notice2.6M$60.4MNoticeSEC
May 3, 2023Rickard Kathleen A.Chief Medical OfficerForm 4 sale106,176$276k3.5%UnusualSEC
May 3, 2023Rickard Kathleen A.OfficerForm 144 notice3,594$75kNoticeSEC
May 1, 2023Poll ClaireGeneral CounselForm 4 sale80,376$207k3.9%RoutineSEC
May 1, 2023Hahn Mark WChief Financial OfficerForm 4 sale455,528$1.2M2.8%UnusualSEC
May 1, 2023Zaccardelli DavidPresident and CEOForm 4 sale455,536$1.2M2.6%UnusualSEC
Mar 9, 2023Orbimed Capital LLCShareholderForm 144 notice311,598$6.4MNoticeSEC
Feb 2, 2023Rickard Kathleen A.Chief Medical OfficerForm 4 sale118,712$303k3.7%UnusualSEC
Feb 1, 2023Hahn Mark WChief Financial OfficerForm 4 sale413,168$1.1M2.5%UnusualSEC
Feb 1, 2023Zaccardelli DavidPresident and CEOForm 4 sale432,928$1.1M2.4%UnusualSEC
Feb 1, 2023Poll ClaireGeneral CounselForm 4 sale152,000$394k16.4%Plan not statedSEC
Dec 23, 2022OrbiMed Capital GP VI LLCDirectorForm 4 sale6.1M$136M15.3%Plan not statedSEC
Dec 23, 2022Gupta RishiDirectorForm 4 sale6.1M$136M15.3%Plan not statedSEC
Dec 22, 2022Poll ClaireGeneral CounselForm 4 sale240,000$646k23.7%Plan not statedSEC
Dec 20, 2022Zaccardelli DavidPresident and CEOForm 4 sale600,000$1.3M3.3%UnusualSEC
Dec 20, 2022Hahn Mark WChief Financial OfficerForm 4 sale600,000$1.3M3.4%UnusualSEC
Nov 1, 2022Zaccardelli DavidPresident and CEOForm 4 sale32,904$55k0.2%Plan not statedSEC
Nov 1, 2022Rickard Kathleen A.Chief Medical OfficerForm 4 sale28,752$47k0.9%Plan not statedSEC
Nov 1, 2022Hahn Mark WChief Financial OfficerForm 4 sale13,160$22k0.1%Plan not statedSEC
Aug 9, 2022Zaccardelli DavidPresident and CEOForm 4 sale600,000$1.1M3.8%UnusualSEC
Aug 9, 2022Hahn Mark WChief Financial OfficerForm 4 sale600,000$1.1M4.0%UnusualSEC
Aug 2, 2022Rickard Kathleen A.Chief Medical OfficerForm 4 sale28,752$20k1.2%Plan not statedSEC
Aug 1, 2022Zaccardelli DavidPresident and CEOForm 4 sale32,904$23k0.2%Plan not statedSEC
Aug 1, 2022Hahn Mark WChief Financial OfficerForm 4 sale13,168$9k0.1%Plan not statedSEC
May 3, 2022Zaccardelli DavidPresident and CEOForm 4 sale32,904$16k0.2%Plan not statedSEC
May 3, 2022Rickard Kathleen A.Chief Medical OfficerForm 4 sale28,752$14k1.2%Plan not statedSEC
May 3, 2022Hahn Mark WChief Financial OfficerForm 4 sale12,512$6k0.1%Plan not statedSEC
Apr 11, 2022Rickard Kathleen A.Chief Medical OfficerForm 4 sale172,520$99k6.3%Plan not statedSEC
Feb 3, 2022Zaccardelli DavidPresident and CEOForm 4 sale52,056$38k0.3%Plan not statedSEC
Feb 2, 2022Hahn Mark WChief Financial OfficerForm 4 sale10,416$8k0.1%Plan not statedSEC
Feb 1, 2022Deschamps LisaDirectorForm 4 sale11,664$9k14.2%Plan not statedSEC
Nov 2, 2021Deschamps LisaDirectorForm 4 sale11,672$8k12.5%Plan not statedSEC
Nov 2, 2021Zaccardelli DavidPresident and CEOForm 4 sale52,056$33k0.3%Plan not statedSEC
Nov 2, 2021Hahn Mark WChief Financial OfficerForm 4 sale10,416$7k0.1%Plan not statedSEC
Aug 4, 2021Zaccardelli DavidPresident and CEOForm 4 sale34,400$26k0.2%Plan not statedSEC
Aug 3, 2021Zaccardelli DavidPresident and CEOForm 4 sale17,656$13k0.1%Plan not statedSEC
Aug 2, 2021Hahn Mark WChief Financial OfficerForm 4 sale10,416$8k0.1%Plan not statedSEC
May 4, 2021Ullman AndersDirectorForm 4 sale12,056$10k3.5%Plan not statedSEC
May 4, 2021Deschamps LisaDirectorForm 4 sale10,680$9k9.2%Plan not statedSEC
May 4, 2021Cunningham KennethDirectorForm 4 sale13,112$11k16.5%Plan not statedSEC
May 4, 2021Sinha VikasDirectorForm 4 sale10,016$8k11.9%Plan not statedSEC
May 4, 2021Ebsworth David RDirectorForm 4 sale11,184$9k1.6%Plan not statedSEC
May 4, 2021Edwards MartinDirectorForm 4 sale12,024$10k9.8%Plan not statedSEC
May 4, 2021Shah MahendraDirectorForm 4 sale10,680$9k12.8%Plan not statedSEC
May 4, 2021Zaccardelli DavidPresident and CEOForm 4 sale52,056$42k0.3%Plan not statedSEC
May 3, 2021Hahn Mark WChief Financial OfficerForm 4 sale10,416$9k0.1%Plan not statedSEC
Mar 1, 2021Hahn Mark WChief Financial OfficerForm 4 sale26,728$30k0.1%Plan not statedSEC
Mar 1, 2021Zaccardelli DavidPresident and CEOForm 4 sale43,392$49k0.2%Plan not statedSEC
Feb 1, 2021Ullman AndersDirectorForm 4 sale10,800$11k3.0%Plan not statedSEC
Feb 1, 2021Sinha VikasDirectorForm 4 sale10,224$10k10.8%Plan not statedSEC
Feb 1, 2021Shah MahendraDirectorForm 4 sale10,800$11k11.4%Plan not statedSEC
Feb 1, 2021Edwards MartinDirectorForm 4 sale13,688$14k10.0%Plan not statedSEC
Feb 1, 2021Ebsworth David RDirectorForm 4 sale11,912$12k1.7%Plan not statedSEC
Feb 1, 2021Cunningham KennethDirectorForm 4 sale13,104$13k14.1%Plan not statedSEC